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Abstract: Balkan endemic nephropathy (BEN) is a chronic kidney disease that affects persons 
living in the Balkans. Despite the unique geographical specificity of this disease, its etiology 
has remained unclear. Even if a positive family history of BEN has been identified, it is still 
uncertain how the disease develops in offspring. In this paper, we examine clinical mechanisms 
related to the onset of BEN in individuals who have a parental history of BEN to identify early 
detection of the disease and formulate interventions. We conducted a 5-year prospective study, 
using markers in years one and three to predict new cases of BEN in year five. New cases of BEN 
were defined based on three criteria: parental history of BEN, reduced kidney size, and reduced 
kidney function. Incident cases were divided into (1) probable, (2) definite, and (3) combined 
labeled total incidence. We evaluated parental history in relation to BEN and tested the potentially 
intervening effects of kidney length, kidney cortex width, β2-microglobulin, C-reactive protein, 
and creatinine clearance, using path analyses. The findings of the path analyses suggested that 
parental history of BEN had both direct and indirect effects. The direct effect was significant 
for all three modes of parental history (biparental, maternal, and paternal; odds ratios 71.5, 
52.3, and 50.1, respectively). The indirect effects of maternal BEN acted via kidney length and 
creatinine clearance. Biparental BEN was mediated by (1) kidney length and creatinine clear-
ance, and (2) creatinine clearance alone. Paternal BEN had three indirect effects: (1) through 
kidney length and creatinine clearance, (2) via kidney cortex width and creatinine clearance, 
and (3) via kidney cortex width only. In conclusion, a family history of BEN led to reduced 
kidney length and cortex width, and a decline in creatinine clearance, which in turn predicted 
the onset of BEN.
Keywords: Balkan endemic nephropathy, incidence of BEN, parental history of BEN, kidney 
size, β2-microglobulin, creatinine clearance
Introduction
Balkan endemic nephropathy (BEN) is a renal disease with an unknown etiology.1,2 
It solely targets the Balkan population.3–5 BEN is not diagnosed in children but is 
discovered in victims when they reach their 50s, suggesting a long latency period. A 
family history of BEN has been demonstrated to increase the risk of this disease.6,7 
Additionally, decreased kidney sizes, reduced creatinine clearance rate (CCr), and 
increased urine excretion, especially of β2-microglobulin, have been illustrated to be 
related to BEN.2,8
Existing literature and prior studies have demonstrated that increased 
β2-microglobulin and reduced kidney length were associated with both BEN patients 
and their healthy offspring.9–15 Moreover, increased C-reactive protein (CRP) and 
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  narrow kidney cortex width were related to a parental history 
of BEN (PHB) before the disease manifestation. A reduced 
CCr was connected to both BEN patients and offspring, 
and it was inversely correlated with kidney sizes in BEN 
patients.9,13,15 Even when an affected family has been verified, 
it is still uncertain how the disease develops in offspring. We 
hypothesized that kidney length and cortex width, CCr, CRP, 
or β2-microglobulin may be intervening factors between PHB 
and BEN development. If we can identify morphological 
and functional changes that lead to BEN in individuals with 
higher risk due to PHB, we may be able to target specific 
interventions.
To respond to this challenge, it is necessary to evaluate 
the effect and direction of biological factors on develop-
mental BEN. One option pursued in this study was firstly to 
track clinical changes over time in adult offspring of BEN 
patients, and secondly to identify links in the relationship 
between PHB and onset of BEN. This would allow us to 
distinguish whether such changes were in the pathway of the 
developmental BEN or were only bystanders. We used path 
analysis to evaluate the various links. This method enabled 
us to study direct and indirect association among PHB, clini-
cal markers, and incidence of BEN simultaneously as a web 
of associations.16
To our knowledge, no study has investigated the pathways 
between PHB and the incidence of BEN. Moreover, out of 
multiple possible markers, we have not identified those that 
link PHB and onset of BEN. Therefore, a hypothetical path 
model (Figure 1) was constructed, bridging the links between 
PHB and new cases of BEN, based upon the literature and 
prior studies. We tested whether or not PHB, which leads to 
new onset of BEN in offspring, is mediated by kidney size, 
function, or serum levels of CRP. If effects of PHB were 
mediated, then intervening variables would be identified. 
If none of the tested morphological and functional changes 
statistically significantly link PHB with the onset of BEN, 
we would conclude that no potential mediators could be 
detected.
Materials and methods
Study design and population
A follow-up study in healthy adult offspring from families 
with and without BEN was conducted in Bulgaria and is 
described in detail elsewhere.10,17 Briefly, 104 adult offspring 
with a PHB were recruited from a hospital database in Vratza, 
where BEN is still endemic. Ninety-seven adult offspring of 
non-BEN parents were frequency-matched with regard to sex 
and 10-year age groups and served as the control group. Both 
study groups were enrolled and examined for the first time 
in 2003–2004 and reexamined four times between 2004 and 
2008. In 2005–2006, 18 participants were newly recruited 
with offspring of BEN patients. The institutional review 
boards of the National Center of Public Health Protection, 
Sofia, Bulgaria, and of the University of South Carolina 
approved the study. Participants provided written consent.
Data collection
Face-to-face interviews were conducted asking participants 
about their birth date and family history of BEN. Both 
  kidneys’ sizes were measured using ultrasound. The longest 
dimension and the smallest thickness of kidney parenchyma 
were determined. Average length and cortex width of both 
kidneys were calculated. β2-microglobulin was measured in 
an aliquot of the hour-one urine sample, and details have 
Demographic:
age, gender
C-reactive protein
Kidney length
Creatinine clearance
Kidney cortex width Parental history
of BEN
Initiation 2005/06 2006/07 2008/09
Incidence of BEN
β2-microglobulin
Figure 1 Hypothesized path diagram.
Note: Arrows represent the effect of one variable on another.
Abbreviation: BEN, Balkan endemic nephropathy.
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been described elsewhere.10 CCr was estimated from serum 
creatinine values by using the Cockcroft–Gault formula18 
and then normalized to body surface area. Serum CRP was 
measured with Immulite (Siemens, Tarrytown, NY) chemi-
luminescent immunometric assay.17
Definition of incidence of BEN
Definite cases of BEN required (1) PHB, (2) reduced kidney size 
(kidney length , 100 mm, kidney cortex width , 11 mm), and 
(3) reduced kidney functions (serum creatinine . 124 µmol/L 
for males and . 106 µmol/L for females; creatinine clear-
ance using the Cockcroft–Gault formula , 60 mL/min; and 
β2-microglobulin . 0.2 mg/g creatinine). Probable BEN cases 
were defined as those with PHB, reduction in either kidney 
length or cortex width, and reduction in at least one kidney 
function marker with repeated measurements. Both groups were 
combined as the incidence of BEN. The criteria we applied 
were central criteria used in previous studies.2,6,8
Statistical analysis
Descriptive statistics were applied to characterize the study 
population. To test the prediction of BEN in 2008–2009, age 
and clinical markers, comprising kidney length and cortex 
width, CCr, β2-microglobulin in 2003–2004 and 2005–2006, 
and CRP in 2006–2007, were used as continuous variables. 
Due to a skewed distribution, β2-microglobulin and CRP were 
log-transformed. In the path analysis, the independent vari-
able ‘PHB’ was analyzed in two ways: (1) as the specific status 
of PHB (biparental, maternal, parental, and   non-BEN); and 
(2) as the dichotomous outcome (yes/no).   An ordinal BEN 
classification (definite, probable, and non-BEN) was used 
as outcome variable. To determine the agreement between 
repeated measurements, we estimated the intraclass correla-
tion coefficient (ICC).19
To test whether kidney sizes, functions, or CRP mediate 
the path from PHB while controlling for age and sex, path 
analyses were applied using Mplus 6 (Muthén and Muthén, 
Los Angeles, CA).20 This method distinguishes three types of 
effects: direct, indirect, and total. Direct effects indicate the 
impact of a risk factor on an outcome not mediated by other 
variables. In Mplus 6, the indirect effect is calculated by the 
product of the coefficient method.21 The total effect of a risk 
factor is the sum of direct and indirect statistical links.16
Our results showed that PHB perfectly predicted the 
occurrence of BEN and caused the maximum likelihood 
estimate for the effect of PHB infinitely. Penalized maximum 
likelihood estimation could be used to resolve this problem.22 
However, since it is not provided in Mplus 6, to ease the 
computing burden, one pseudo-BEN case was generated by 
a random selection among the non-BEN subjects with no 
parental history.
Estimates in Mplus 6 for incidence of BEN are shown 
as logit coefficients in the path analyses and are transformed 
to odds ratios (ORs = exp [logit coefficient]) to explain the 
strength of the association. Regarding kidney length and 
cortex width, CCr, CRP, and β2-microglobulin, the estimation 
of coefficients are linear regression coefficients.20 Per unit 
increase in the independent variable, the effect is estimated 
by multiplying the estimated path coefficient with the unit 
increase in the dependent variable.
Mplus 6 provides the Akaike information criterion and 
Bayesian information criterion as indicators of the model fit; 
the smaller the model indicators, the better the fit.20   Selecting 
a model involves simultaneously fitting a series of linear 
regressions and logistic regressions and then choosing the 
model for the best fit.
Results
A total of 219 participants were enrolled in this study, and 177 
(80.8%) remained in the last year of follow-up. Over a 5-year 
period, 38 (17.4%) offspring with a parental history of BEN 
developed the disease, of which 6.8% and 10.5% developed 
definite and probable BEN, respectively, whereas offspring 
without a parental history of BEN did not develop BEN.
Participants with definite BEN were older, had the 
smallest kidney length and cortex width, and presented high 
β2-microglobulin levels (Table 1). Moreover, about 50% of 
participants with definite BEN had a maternal history of 
BEN. Definite BEN was equally frequent in women and 
men. In the paternal BEN group, more probable BEN cases 
were found. Women were slightly more likely to develop 
probable BEN (Table 1).
Regarding rank correlations of age and clinical mark-
ers, most were moderately correlated with age and each 
other (P , 0.05, Table 2). Maternal BEN was correlated 
with kidney length (P = 0.009). A high agreement between 
measurements of kidney length and cortex width in left and 
right kidneys (ICC = 0.99) over the course of two repeated 
assessments was detected (ICC = 0.98, data not shown). 
Regarding kidney function (CCr and β2-microglobulin), the 
ICCs over the course of two repeated examinations were 
0.99 for both markers.
Model with PHB (yes/no) as predictor
Statistically significant path coefficients for this model are 
presented in Figure 2. Single-headed arrows in the path 
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Table 1 Characteristics of participants stratified by incidence of BEN in year 2005–2006
Variables Definite BEN 
(n = 15) 
N cases (%)
Probable BEN 
(n = 23) 
N cases (%)
No BEN 
(n = 162) 
N cases (%)
Sex
  Female 8 (53.33) 14 (60.87) 84 (51.85)
Parental history of BEN
  Biparental 5 (33.33) 8 (34.78) 21 (12.96)
  Mother 8 (53.33) 6 (26.09) 26 (16.05)
  Father 2 (13.33) 9 (39.13) 23 (14.20)
Living in endemic area
  ,20 years 0 (0.00) 2 (8.70) 22 (13.58)
  21–40 years 3 (20.00) 3 (13.04) 64 (39.51)
 $ 41 years 12 (80.00) 18 (78.86) 76 (46.91)
Body mass index
  Overweight 11 (73.33) 10 (43.48) 69 (42.59)
  Obesity 2 (13.33) 9 (39.13) 42 (25.93)
History of other kidney disease
  Pyelonephritis 3 (20.00) 2 (8.70) 8 (4.97)
  Other (stone, cystitis, cancer) 3 (20.00) 4 (17.39) 22 (13.66)
Smoking status
  Current 4 (26.67) 4 (17.39) 60 (37.64)
  Exsmoker 1 (6.67) 0 (0.00) 4 (2.47)
Mean (95% CI, or 5%, 95%)
Age (year) 61.26 (56.79, 65.74) 54.78 (51.46, 58.11) 49.69 ( 48.26, 51.10)
Kidney length (mm) 109.88 (102.64, 117.02) 113.20 (109.74, 116.64) 119.03 (117.94, 120.13)
Kidney cortex width (mm) 12.99 (11.72, 14.25) 14.65 (13.81, 16.65) 16.07 (15.79, 16.35)
CCr (mL/min/1.73 m2) 73.23 (62.68, 81.78) 83.67 (78.80, 88.65) 91.03 (88.42, 93.65)
CRPa (mg/dL) 0.50 (0.08, 3.43) 0.44 (0.09, 1.71) 0.27 (0.06, 1.73)
β2Ma (µg/g creatinine) 123.56 (75.77, 892.29) 114.89 (38.72, 800.00) 108.02 (47.84, 363.28)
Note: aMedian.
Abbreviations: CCr, creatinine clearance rate; BEN, Balkan endemic nephropathy; β2M, β2-microglobulin; CRP, C-reactive protein.
diagrams demonstrate the effect of a PHB on outcome vari-
ables (kidney length, kidney cortex width, CCr, or incidence 
of BEN). Single-headed arrows with a solid line represent 
a direct effect while those with a dotted line demonstrate 
an indirect effect. The curved line with arrows at each end 
indicates a correlation between variables. The value on each 
line represents the path coefficient.
Participants with a PHB were associated with small 
kidney length and cortex width and increased CRP level. 
A reduction of the kidney cortex width of 10 mm increased 
β2-microglobulin by about 6 µg/g creatinine. There 
were positive associations between CCr and both kidney 
length and cortex width in all participants. No association 
was identified between PHB and β2-microglobulin or between 
CRP and either kidney size or function. Kidney cortex 
width, CCr, and PHB were directly related to the occurrence 
of BEN. Offspring with a PHB were 57 times more likely to 
develop BEN than persons without a PHB (exponential of 
4.05, Figure 2). A reduction of kidney cortex width of 1 mm 
increased the risk of having BEN (OR = 0.74; exponential of 
−0.29). Furthermore, a decline in CCr was associated with 
the occurrence of BEN (OR = 0.94; exponential of −0.06). 
No direct associations between CRP, kidney length, or 
β2-microglobulin and new cases of BEN were detected. We 
also found that PHB was indirectly associated with the occur-
rence of BEN through decreased kidney length or kidney 
cortex width and reduced CCr. Another pathway was medi-
ated by kidney cortex width alone. When all variables were 
included, 64.3% of the incidence of BEN was explained.
Model with specific status of PHB  
as predictor
When examining the model using the specific PHB, we found 
that short kidney length and increased CRP level were related 
to participants with a maternal history of BEN (Figure 3). 
Increased CCr and CRP levels in participants were related 
to a biparental history of BEN. No association was identified 
between any PHB and β2-microglobulin or between CRP and 
either kidney size or function.
Statistically significant direct associations were observed 
between the incidence of BEN and all three PHBs, indicating 
that a major part of the effect of PHB on the onset of BEN 
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Table 2 Rank correlation coefficients (Spearman) of parental history, age, and clinical markers
n = 219 n = 198 n = 219
Age  
(years)
Kidney cortex  
width
Kidney  
length
CCr β2M CRP Biparental Mother Father
Age (year) 1.00
Kidney cortex width −0.421* 1.00
Kidney length −0.192* 0.363* 1.00
CCr −0.641* 0.458* 0.294* 1.00
β2M 0.281* −0.273* 0.003 −0.212* 1.00
CRP 0.236* −0.146* −0.015 −0.113 0.071 1.00
Biparental 0.183* −0.067 −0.084 −0.040 −0.045 0.179* 1.00
Mother 0.133* −0.047 −0.176* −0.093 0.072 0.131 −0.237* 1.00
Father −0.181* −0.066 −0.012 0.051 −0.029 −0.038 −0.127* −0.237* 1.00
Note: *P value , 0.05.
Abbreviations: CCr, creatinine clearance rate; BEN, Balkan endemic nephropathy; β2M, β2-microglobulin; CRP, C-reactive protein.
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Figure 2 Direct and indirect path linking parental Balkan endemic nephropathy (BEN) and the incidence of BEN. 
Notes: The unstandardized (standard error) parameter estimates are shown. The dotted line presents a significant statistic (P , 0.05) of an indirect association between 
parental history of BEN and the occurrence of BEN. The solid line shows a statistically significant direct effect between parental history of BEN and the occurrence of BEN 
(P , 0.05). The underlined coefficients are logit coefficients and need to be exponentiated to calculate odds ratios. The nonunderlined coefficients are interpreted as linear 
regression coefficients: per unit of increase in the independent variable there will be a coefficient unit of increase in the dependent variable. The curved line with arrows at 
each end indicates a correlation between variables.
was not mediated by clinical markers. Those offspring with a 
biparental BEN status were 71.5 times more likely to develop 
BEN than those without a PHB (OR = exponential of 4.27, 
Figure 3). Participants with a maternal history of BEN were 
52.3 times more likely to develop BEN, while those with a 
paternal history of BEN were 50.1 times more likely to develop 
the disease than those without a PHB (OR = exponential of 
3.91). A reduction of kidney cortex width of 1 mm increased 
the risk of having BEN (OR = 0.75; exponential of −0.28). 
Also, an increase in CCr was associated with lower occur-
rence of BEN (OR = 0.94; exponential of −0.059). No direct 
associations between CRP, kidney length, or β2-microglobulin 
and new cases of BEN were detected.
There were several indirect impacts of PHB on the onset 
of BEN (Figure 3). We found that maternal history of BEN 
had an indirect effect on BEN through reduced kidney 
length, which then affected CCr. Paternal history of BEN 
had three indirect effects on developing BEN: mediated by 
kidney length and CCr, by kidney cortex width and CCr, 
and by kidney cortex width alone. The indirect paths of 
biparental history on BEN were mediated by two clinical 
markers (kidney length and CCr) and CCr only. Overall, 
the model accounted for 67.3% of the variability in the 
incidence of BEN.
For both models in Figures 2 and 3, age and sex were not 
associated with the occurrence of BEN; however, an increase 
in age and being female were statistically significantly asso-
ciated with almost all clinical markers. Thus, both factors 
indirectly affected BEN via CCr or kidney cortex width. All 
models fit well, with the smallest of the Akaike information 
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criterion and Bayesian information criterion. The goodness 
of fit was high for all models.
Discussion
This paper aimed to examine whether the association between 
PHB and incidence of BEN was mediated by such clinical 
markers as kidney sizes, kidney functions, and serum CRP. 
The results showed that PHB to a large extent directly influ-
enced new occurrence of BEN. However, the effect of PHB 
on new cases was partially mediated through kidney sizes, 
kidney cortex width, and CCr. Maternal history influenced 
the occurrence of new cases via kidney length and CCr. 
  Biparental BEN had two pathways: through kidney length 
and CCr, and through CCr only. There were three indirect 
associations between paternal history of BEN and new onset: 
(1) small kidney length resulting in decreased CCr, (2) small 
kidney cortex width and decline in CCr, and (3) declined 
kidney cortex width. The web of associations also indicated 
that CCr was an important intervening factor between 
parental history of BEN and new cases; however, CRP and 
β2-microglobulin did not act as intervening variables.
Our findings are unlikely to have resulted from a selection 
bias, as a high follow-up proportion of participants remained at 
the end of study (81%). Information bias, if any, was minimal, 
since identical diagnosis criteria of BEN were applied to detect 
the outcome during the follow-up period, and there was a high 
agreement of measurements of clinical markers over time, such 
as kidney dimensions, function, and CCr.
We found that short kidney length was indirectly 
  associated with BEN through decreased CCr. Kidney cortex 
width directly influenced the onset of BEN and was also 
mediated through CCr. Our results demonstrated that kidney 
sizes had a direct effect (kidney cortex width) and an indirect 
effect (kidney length). These findings support autopsy studies 
of BEN patients indicating cortical sclerosing atrophy in the 
early stage of BEN.23,24
In agreement with the literature, a decrease of CCr 
directly increased the risk of BEN.9,25 Other studies have 
also reported that β2-microglobulin excretion was higher in 
BEN patients and their offspring,10,12 yet we did not detect an 
association between β2-microglobulin, parental history, and 
the development of BEN. One explanation for this difference 
is that β2-microglobulin may not be a part of the pathologi-
cal development but only a bystander or may be increased 
after the disease manifests, resulting from a reduced kidney 
cortex width.
Unexpectedly, CRP was neither directly nor indirectly 
related to BEN. However, we found that CRP was associated 
with parental history, agreeing with a prior study.17 Since a 
PHB is an important risk factor for BEN, it is possible that 
other inflammatory pathways are involved in the develop-
ment of BEN. Further studies on inflammatory markers are 
warranted.
The present study focuses on PHB instead of   family 
history, since PHB is less likely to create information 
biases compared to the collection of the history of BEN in 
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Notes: The unstandardized (standard error) parameter estimates are shown. The dotted line presents a significant statistic (P , 0.05) of an indirect association between 
parental history of BEN and the occurrence of BEN. The solid line shows a statistically significant direct effect between parental history of BEN and the occurrence of BEN 
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grandparents or other relatives. As expected, PHB had a 
direct effect on the onset of BEN, indicating that PHB is an 
important risk factor.26,27 Participants with biparental history 
were more likely to develop BEN than those with a maternal 
or paternal history.1
The association between PHB and incidence of BEN 
seems to have a variety of different pathways (Figure 3). 
Maternal BEN acted through kidney length, paternal BEN 
acted via kidney length and kidney cortex width, and bipa-
rental BEN indirectly affected the incidence of BEN via 
kidney length and CCr. It is likely that kidney sizes and 
CCr are significant mediators between parental status and 
development of BEN. Further studies specifying the web 
of associations between parental BEN, risk factors, and the 
incidence of BEN are needed.
It has been documented in healthy persons that kidney 
sizes are associated with renal parenchymal mass and the 
total number of nephrons and that their number decreases 
with age,28,29 resulting in the reduction of kidney cortex width 
and decrease in kidney function.30 In the case of BEN, it is 
possible that offspring with BEN may have a small kidney 
size at birth due to a reduction in the number of nephrons,31 
suggesting a maternal influence as demonstrated before.10 
This assumption is based on the idea that the onset of BEN 
occurs in childhood, has a long latency period, and then 
clinically manifests itself at a later age.4 There is a need to 
determine kidney size of BEN offspring at birth or early in 
life and then follow them up frequently.
Since 64.3% of the incidence of BEN was explained, 
our findings support the hypothesized model. However, this 
does not exclude the possibility of other causal models and 
additional risk factors. For example, other clinical markers 
and possible exposures to environmental factors could be 
included in future path models to improve the explanation of 
BEN. Given that a reduction of kidney length, kidney cortex 
width, and CCr played a central role in mediating parental 
status of BEN with new occurrence of BEN in offspring, 
it is important to intervene by preventing a reduction of 
these markers due to other risk factors such as smoking and 
obesity.32–34
Conclusion
Our findings provide evidence elucidating the relationship 
between parental history of BEN (PHB) and incidence of 
BEN. First, we demonstrated that parental history has both 
a direct and an indirect effect. Second, we found several path 
links between PHB and occurrence of BEN: (1)   maternal 
BEN acting via kidney length, (2) paternal BEN acting 
via kidney length or cortex width, and (3) biparental BEN 
  acting via kidney length or CCr. Third, we demonstrated 
that β2-microglobulin excretion and CRP were bystanders 
and not involved in the pathway. Our results suggest the 
need for additional studies to corroborate our findings and 
to explore further the effect of additional factors on the 
development of BEN.
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